Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jinxin Fertility Group Ltd. ( (HK:1951) ) has provided an update.
Jinxin Fertility Group Ltd. has announced a proposed adoption of the 2025 Share Scheme, aiming to align the interests of its directors and key employees with the company’s long-term growth objectives. The scheme includes conditional grants of options and restricted shares to management and non-executive grantees, pending shareholder approval at an upcoming extraordinary general meeting.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.80 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the healthcare industry, focusing on fertility services. The company is incorporated under the laws of the Cayman Islands and is listed on the Stock Exchange of Hong Kong.
Average Trading Volume: 89,960,775
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.71B
See more data about 1951 stock on TipRanks’ Stock Analysis page.